4Front Holdings, LLC (“4Front”), a diversified operator of strategically aligned cannabis-related businesses, including cultivation, production and retail operations, is pleased to announce it has secured a $50 million loan (the “Loan”) from LI Lending, LLC (“LI Lending”) to support the expansion and buildout of 4Front’s cultivation and production facilities ahead of its anticipated business combination with Cannex Capital Holdings Inc. (CSE:CNNX; OTCQX:CNXXF).

The Loan’s terms include:


  • A five-year term
  • An interest rate of 10.25%
  • A 20% repayment premium at maturity

Importantly, the Loan is non-dilutive, not convertible, does not include warrants or similar equity instruments nor a prepayment penalty.

“We have had detailed discussions with several prospective lenders over the last two years, but LI Lending offered terms materially better than others,” said Josh Rosen, CEO and co-founder of 4Front. “In addition, our lender has a ground-up understanding of cannabis production and processing facilities.”

4Front’s anticipated business combination with Cannex has been approved by Cannex shareholders and is awaiting final approval from U.S. antitrust authorities. The resulting combined entity is planned to be named 4Front Ventures.

About 4Front Holdings
4Front is building a next-generation company in the cannabis industry, based upon strategic and aligned leadership, battle-tested operating capabilities, transparent and principled governance, and a commitment to developing and supporting people and communities. Led by a group of professionals with experience in strategy, manufacturing, distribution & logistics, finance, real estate, multi-location retail & hospitality operations and talent development & retention, 4Front has invested heavily to assemble a comprehensive collection of management skills and hands-on operating expertise that can support the rapid operational growth opportunity being afforded by the increased legalization of cannabis across the globe. For more information, visit 4Front’s website.

Media Contacts
Anne Donohoe / Nick Opich
KCSA Strategic Communications
adonohoe@kcsa.com / nopich@kcsa.com
212-896-1265 / 212-896-1206

Related Links

Front

Click here to connect with Cannex Capital Holdings Inc. (CSE:CNNX; OTCQX:CNXXF) for an Investor Presentation. 

Source: www.prnewswire.com

American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.

Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.

Keep reading... Show less

An Emerging Markets Sponsored Commentary

Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.

Keep reading... Show less

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less